Clinical Trials for Pathos AI

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Pathos AI

Clinical Trials (1)

NCT06785636
Open-Label Study of Pocenbrodib Alone and in Combination With Abiraterone Acetate, Olaparib, or 177Lu-PSMA-617
PHASE1/PHASE2Recruiting
252 participants
Started: Feb 7, 2025 · Completed: Apr 30, 2029
10 conditions2 sponsors8 locations